Giant cell arteritis: Epidemiology, diagnosis, and management

被引：62

作者：

Gonzalez-Gay M.A. ^{[1
]}

Martinez-Dubois C. ^{[1
]}

Agudo M. ^{[1
]}

Pompei O. ^{[1
]}

Blanco R. ^{[1
]}

Llorca J. ^{[1
]}

机构：

[1] Rheumatology Division, Hospital Universitario Marques de Valdecilla, IFIMAV, Santander, Cantabria 39008, Avenida de Valdecilla s/n

来源：

Current Rheumatology Reports | 2010年 / 12卷 / 6期

关键词：

Corticosteroids; Giant cell arteritis; Incidence; Temporal artery biopsy; Ultrasonography;

D O I：

10.1007/s11926-010-0135-9

中图分类号：

学科分类号：

摘要：

Giant cell arteritis (GCA), also called temporal arteritis, is a vasculitis that affects large and middle-sized blood vessels-with predisposition to the involvement of cranial arteries derived from the carotid artery-in individuals older than 50 years of age. Familial aggregation of GCA has been observed. Incidence of GCA is higher in white individuals than those of other ethnicities, particularly those of Scandinavian background. A temporal artery biopsy is the gold standard test for the diagnosis of GCA. Several imaging modalities, in particular ultrasonography, are useful in the diagnosis of GCA. Corticosteroids are the cornerstone of treatment in GCA. Alternative, steroid-sparing drugs, particularly methotrexate, should be considered in GCA patients with severe corticosteroid-related side effects and/or in those who require prolonged corticosteroid therapy due to relapses of the disease. © 2010 Springer Science+Business Media, LLC.

引用

页码：436 / 442

页数：6

共 50 条

[1]

Salvarani C., Cantini F., Hunder G.G., Polymyalgia rheumatica and giant-cell arteritis, The Lancet, 372, 9634, pp. 234-245, (2008)

[2]

Gonzalez-Gay M.A., Vazquez-Rodriguez T.R., Lopez-Diaz M.J., Et al., Epidemiology of giant cell arteritis and polymyalgia rheumatica, Arthritis Rheum, 61, pp. 1454-1461, (2009)

[3]

Liozon E., Ouattara B., Rhaiem K., Et al., Familial aggregation in giant cell arteritis and polymyalgia rheumatica: A comprehensive literature review including 4 new families, Clin Exp Rheumatol, 27, SUPPL. 52, (2009)

[4]

Gonzalez-Gay M.A., Amoli M.M., Garcia-Porrua C., Ollier W.E.R., Genetic markers of disease susceptibility and severity in giant cell arteritis and polymyalgia rheumatica, Seminars in Arthritis and Rheumatism, 33, 1, pp. 38-48, (2003)

[5]

Gonzalez-Gay M.A., Miranda-Filloy J.A., Lopez-Diaz M.J., Perez-Alvarez R., Gonzalez-Juanatey C., Sanchez-Andrade A., Martin J., Llorca J., Giant cell arteritis in northwestern Spain: A 25-year epidemiologic study, Medicine, 86, 2, pp. 61-68, (2007)

[6]

Gonzalez-Gay M.A., Blanco R., Sanchez-Andrade A., Vazquez-Caruncho M., Giant cell arteritis in Lugo, Spain: A more frequent disease with fewer classic features, J Rheumatol, 24, pp. 2166-2170, (1997)

[7]

Lopez-Diaz M.J., Llorca J., Gonzalez-Juanatey C., Et al., Implication of the age in the clinical spectrum of giant cell arteritis, Clin Exp Rheumatol, 26, SUPPL. 49, (2008)

[8]

Kermani T.A., Schafer V.S., Crowson C.S., Et al., Increase in age at onset of giant cell arteritis: A population-based study, Ann Rheum Dis, 69, pp. 780-781, (2010)

[9]

Salvarani C., Gabriel S.E., O'Fallon W.M., Hunder G.G., The incidence of giant cell arteritis in Olmsted County, Minnesota: Apparent fluctuations in a cyclic pattern, Ann Intern Med, 123, pp. 192-194, (1995)

[10]

Petursdottir V., Johansson H., Nordborg E., Nordborg C., The epidemiology of biopsy-positive giant cell arteritis: Special reference top cyclic fluctuations, Rheumatology (Oxford), 38, pp. 1208-1212, (1999)

← 1 2 3 4 5 →